They seemed to be sceptical about biotechs in general, without being familiar with the RAC story and how it's already proven efficacy in prior trials. Hopefully this interview sheds some more light.
One of the guests on the podcast linked here before spoke about a customer of theirs who has held RAC since it was in the cents, and they try to talk them into selling or at least derisking but the client refuses, they really believe in the RAC potential.
The hype is building!
They seemed to be sceptical about biotechs in general, without...
-
- There are more pages in this discussion • 17,772 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.88 |
Change
0.025(1.35%) |
Mkt cap ! $319.4M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.89 | $1.85 | $74.38K | 39.92K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 18943 | $1.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.88 | 199 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |